HomeDXCM • NASDAQ
add
DexCom Inc
Previous close
$70.43
Day range
$70.03 - $73.24
Year range
$54.11 - $91.87
Market cap
28.02B USD
Avg Volume
6.16M
P/E ratio
35.30
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.26B | 13.12% |
Operating expense | 469.70M | 0.60% |
Net income | 267.30M | 76.20% |
Net profit margin | 21.22 | 55.80% |
Earnings per share | 0.68 | 51.11% |
EBITDA | 388.20M | 57.36% |
Effective tax rate | 21.54% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.00B | -22.51% |
Total assets | 6.34B | -2.23% |
Total liabilities | 3.59B | -17.98% |
Total equity | 2.75B | — |
Shares outstanding | 384.86M | — |
Price to book | 9.86 | — |
Return on assets | 11.67% | — |
Return on capital | 17.10% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 267.30M | 76.20% |
Cash from operations | 294.00M | -2.46% |
Cash from investing | 306.60M | 200.95% |
Cash from financing | -1.52B | -95,037.50% |
Net change in cash | -917.80M | -5,978.15% |
Free cash flow | 85.75M | -42.68% |
About
Dexcom, Inc. is an American healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
11,050
